Press Releases
TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief
TraceLink Inc., the leading digital platform company for the life sciences industry, announced a new package of agile solutions designed to digitalize the pharmaceutical supply chain. In response to COVID-19, TraceLink has prioritized its product roadmap and investment strategy...
Press Releases
How the Coronavirus Pandemic Is Impacting Global Shipping and Logistics – And How Cryoport Can Help
As the world experiences unprecedented times caused by the COVID-19 pandemic, Cryoport has been collaborating closely with our clients to help navigate this dynamic environment and to ensure successful shipments of precious biomaterials. However, it is clear in our...
Press Releases
Breakthrough in COVID-19 Testing: ITRI Develops Nucleic Acid Detection System for 1-Hour Rapid Tests
Amid the war against the COVID-19 pandemic, the Industrial Technology Research Institute (ITRI), the largest applied research institute in Taiwan, is turning to its technological prowess to fight the virus and prohibit its spreading. The institute has formed a...
Press Releases
PharmaBlock Opens New Chemistry and Engineering Technology Center in Zhejiang
Early this April, PharmaBlock Sciences (Nanjing), Inc. announced the launch of a new Chemistry and Engineering Technology Center (CETC) located next to its GMP manufacturing site in Shangyu, Zhejiang Province. Addition of the CETC will further strengthen PharmaBlock’s chemistry...
Press Releases
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
Sanofi will contribute its S-protein COVID-19 antigen, which is...
Press Releases
Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19
People with diabetes using Novo Nordisk Inc. insulin who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic may now be eligible for enrollment in our Diabetes Patient Assistance Program (PAP)...
Press Releases
Labguru announces $1M pro-bono program for COVID-19 treatment developers
BioData is offering a pro-bono programme allowing free access to its flagship Labguru electronic laboratory notebook (ELN) to academic laboratories, non-profit organizations and small start-ups working on COVID-19 treatment or vaccine development, up to a total value of $1M.
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read